Furthermore, caspase-3 activity was decreased by 43.6% in the DM + liraglutide group compared with the DM group (DM + liraglutide group: 0.22 ± 0.07 vs. DM group: 0.39 ± 0.10) (p<0.05) (Fig 3). The gene discussed is CASP3; the disease is diabetes mellitus.